Study wrapper · #1306
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.
Editor's note
The novelty here is manufacturing rather than biology: a chromosomally integrated Bacillus expression system intended to make BPC 157 cheaper to produce at scale. The rat gastric-ulcer data are supportive but secondary, and the molecules given to animals were fusion constructs (GGT-BPC157 and mScarlet-BPC157), not free BPC 157, so the potency figures cannot be read across to the peptide sold under that name. There is no head-to-head comparison against synthetic peptide, no described blinding, and no human data.
Plain-language abstract
Researchers engineered a bacterium, Bacillus licheniformis, to manufacture BPC 157 attached to a larger carrier protein, then tuned the fermentation recipe until output roughly tripled. They gave the purified fusion proteins to rats with alcohol-induced stomach ulcers and measured ulcer area and inflammatory signals. Ulcer damage was 75 to 85 percent lower than in control animals, and three inflammatory markers fell in stomach tissue. All of the work was done in bacteria and rats.